|
May 9
|
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
|
|
May 9
|
Health Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapy
|
|
May 9
|
Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
|
|
May 8
|
Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for Mothers
|
|
May 8
|
Q1 2024 OPKO Health Inc Earnings Call
|
|
May 8
|
Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
|
|
May 6
|
Gossamer sells rights to drug it hopes can rival a new Merck therapy
|
|
May 6
|
Merck First Quarter 2024 Earnings: Beats Expectations
|
|
May 3
|
Here's Why Merck (MRK) is a Strong Momentum Stock
|
|
May 2
|
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
|
|
May 1
|
15 Best Places to Retire in Florida That You’ve Never Heard Of
|
|
May 1
|
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
|
|
May 1
|
3 Pharma Stocks With the Potential to Make You an Overnight Millionaire
|
|
Apr 30
|
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
|
|
Apr 29
|
Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
|
|
Apr 27
|
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
|
|
Apr 25
|
Merck (MRK) Q1 2024 Earnings Call Transcript
|
|
Apr 25
|
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
|
|
Apr 25
|
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
|
|
Apr 25
|
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
|